Drug survival of conventional systemic and biologic therapies for moderate-to-severe psoriasis in clinical practice in Spain: prospective results from the SAHARA study-Reference-Cited by-同舟云学术

Drug survival of conventional systemic and biologic therapies for moderate-to-severe psoriasis in clinical practice in Spain: prospective results from the SAHARA study

Published:2019-06-20 Issue:4 Volume:31 Page:344-351
ISSN:0954-6634
Container-title:Journal of Dermatological Treatment
language:en
Short-container-title:Journal of Dermatological Treatment

Author:

Puig Luis¹^ORCID,Carrascosa José-Manuel²^ORCID,Daudén Esteban³,Sulleiro Sara⁴,Guisado Cristina⁴

Affiliation:

1. Department of Dermatology, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain;

2. Department of Dermatology, Hospital Universitario Germans Trias i Pujol, Barcelona, Spain;

3. Department of Dermatology, Hospital Universitario La Princesa, Madrid, Spain;

4. Medical Department, Janssen, Madrid, Spain

Funder

Janssen

Publisher

Informa UK Limited

Subject

Dermatology

Link

https://www.tandfonline.com/doi/pdf/10.1080/09546634.2019.1597244

Reference30 articles.

1. Directrices españolas basadas en la evidencia para el tratamiento de la psoriasis con agentes biológicos, 2013. I. Consideraciones de eficacia y selección del tratamiento

2. Differential Drug Survival of Second-Line Biologic Therapies in Patients with Psoriasis: Observational Cohort Study from the British Association of Dermatologists Biologic Interventions Register (BADBIR)

3. Medication Compliance and Persistence: Terminology and Definitions

4. Persistence with anti-tumor necrosis factor therapies in patients with psoriatic arthritis: observational study from the British Society of Rheumatology Biologics Register

5. Drug survival rates and reasons for drug discontinuation in psoriasis

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and safety of piclidenoson in plaque psoriasis: Results from a randomized phase 3 clinical trial (COMFORT‐1);Journal of the European Academy of Dermatology and Venereology;2024-01-26

2. Use of systemic and biological therapy in patients with moderate-to-severe psoriasis;Clinical and Experimental Dermatology;2023-08-23

3. Drug survival of methotrexate and predictor factors for discontinuation in psoriasis;International Journal of Dermatology;2023-03-24

4. Survival rates of systemic interventions for psoriasis in the Western Japan Psoriasis Registry: A multicenter retrospective study;The Journal of Dermatology;2023-02-14

5. Plaque-Psoriasis: Moderne Therapien auch bei Komorbiditäten möglich;Deutsches Ärzteblatt Online;2022-11-11